NCT00677690

Brief Summary

The purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at below P25 for phase_3 chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jan 2007

Typical duration for phase_3 chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 14, 2008

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
4 months until next milestone

Results Posted

Study results publicly available

April 20, 2009

Completed
Last Updated

November 16, 2011

Status Verified

November 1, 2011

Enrollment Period

1.2 years

First QC Date

May 8, 2008

Results QC Date

January 5, 2009

Last Update Submit

November 4, 2011

Conditions

Keywords

COPD

Outcome Measures

Primary Outcomes (2)

  • Exercise Capacity

    6 minute walk test(6MWT)

    5 weeks

  • Quadriceps Strength

    Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.

    5 weeks

Secondary Outcomes (3)

  • Dyspnoea

    5 weeks

  • Quality of Life

    5 weeks

  • Respiratory Function

    5 weeks

Study Arms (2)

NM+PR

ACTIVE COMPARATOR

Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation (NM+PR)

Other: neuromuscular electrical stimulation (NMES)

SS+PR

PLACEBO COMPARATOR

Patients undergone to pulmonary rehabilitation

Other: Sham electrical stimulation

Interventions

NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current. Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.

Also known as: pulmonary rehabilitation
NM+PR

Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.

Also known as: pulmonary rehabilitation
SS+PR

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of COPD
  • Must be able to walk

You may not qualify if:

  • Previous or current diagnosis of chronic respiratory failure
  • A history of diseases other than COPD, in particular neurological disease
  • Need for treatment with systemic steroids during the rehabilitation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Salvatore Maugeri

Montescano, Pavia, 27040, Italy

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Ercole Zanotti
Organization
Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy

Study Officials

  • ercole zanotti, MD

    Fondazione Maugeri

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 8, 2008

First Posted

May 14, 2008

Study Start

January 1, 2007

Primary Completion

March 1, 2008

Study Completion

January 1, 2009

Last Updated

November 16, 2011

Results First Posted

April 20, 2009

Record last verified: 2011-11

Locations